PI
TEVA icon

PineBridge Investments’s Teva Pharmaceuticals TEVA Stock Holding History

PineBridge Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-22,566
Closed -$397K – 1143
2017
Q3 		$397K Sell
22,566
-7,796
-26% -$175K 0.01% 731
2017
Q2 		$1.01M Sell
30,362
-2,537
-8% -$78.5K 0.03% 497
2017
Q1 		$1.06M Buy
+32,899
New +$1.12M 0.03% 480
2016
Q2 		– Sell
-138,124
Closed -$7.39M – 1170
2016
Q1 		$7.39M Buy
+138,124
New +$8.1M 0.38% 88

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

PineBridge Investments's TEVA Position: Q4 2017 in Review

PineBridge Investments sold out of Teva Pharmaceuticals (TEVA) in Q4 2017, closing a stake of 22,566 shares — an estimated $397K sold.

PineBridge Investments first reported a position in TEVA in Q1 2016 and held it in 4 quarters. The position peaked at $7.39M in Q1 2016. 507 funds tracked by Wall St. Rank hold TEVA as of Q4 2017.

  • PineBridge Investments reported no remaining Teva Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • PineBridge Investments sold 22,566 Teva Pharmaceuticals shares in Q4 2017, an estimated $397K.
  • PineBridge Investments first reported a position in Teva Pharmaceuticals in Q1 2016 and held it in 4 quarters.
  • PineBridge Investments's Teva Pharmaceuticals position peaked at $7.39M in Q1 2016.
  • 507 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2017.

Based on PineBridge Investments's 13F filing for Q4 2017, filed 9 Feb 2018.